The impact of PET scanning on management of paediatric oncology patients
| Autor: | Sally F. Barrington, Richard O. Robinson, Michael O'Doherty, J E Kingston, M Taj, Eva Wegner, Rosalie E. Ferner, M A Smith |
|---|---|
| Rok vydání: | 2004 |
| Předmět: |
Male
medicine.medical_specialty Adolescent Attitude of Health Personnel Population Pediatrics Risk Assessment Plexiform neurofibroma Risk Factors Neoplasms Surveys and Questionnaires medicine Humans Radiology Nuclear Medicine and imaging Practice Patterns Physicians' education Child education.field_of_study medicine.diagnostic_test Paediatric oncology business.industry Infant Newborn Cancer Infant General Medicine medicine.disease Prognosis United Kingdom Lymphoma Positron emission tomography Child Preschool Positron-Emission Tomography Orthopedic surgery Female Sarcoma Radiology business |
| Zdroj: | Europe PubMed Central |
| ISSN: | 1619-7070 |
| Popis: | Limited information is available on the use of positron emission tomography (PET) in paediatric oncology. The aim of this study was to review the impact of PET on the management of paediatric patients scanned over a 10-year period. One hundred and sixty-five consecutive oncology patients aged 11 months to 17 years were included. Two hundred and thirty-seven scans were performed. Diagnoses included lymphoma (60 patients), central nervous system (CNS) tumour (59), sarcoma (19), plexiform neurofibroma with suspected malignant change (13) and other tumours (14). A questionnaire was sent to the referring clinician to determine whether the PET scan had altered management and whether overall the PET scan was thought to be helpful. One hundred and eighty-nine (80%) questionnaires for 126 patients were returned (63 relating to lymphoma, 62 to CNS tumours, 30 to sarcoma, 16 to plexiform neurofibroma and 18 to other tumours). PET changed disease management in 46 (24%) cases and was helpful in 141 (75%) cases. PET findings were verified by histology, clinical follow-up or other investigations in 141 cases (75%). The returned questionnaires indicated that PET had led to a management change in 20 (32%) lymphoma cases, nine (15%) CNS tumours, four (13%) sarcomas, nine (56%) plexiform neurofibromas and four (22%) cases of other tumours. PET was thought to be helpful in 47 (75%) lymphoma cases, 48 (77%) CNS tumours, 24 (80%) sarcomas, 11 (69%) neurofibromas and 11 (61%) cases of other tumours. PET findings were verified in 44 (70%) lymphoma cases, 53 (85%) CNS tumours, 21 (70%) sarcomas, 12 (75%) neurofibromas and 11 (61%) other tumour cases. PET imaging of children with cancer is accurate and practical. PET alters management and is deemed helpful (with or without management change) in a significant number of patients, and the results are comparable with the figures published for the adult oncology population. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink